Physical growth and retinopathy in preterm infants: Involvement of IGF-I and GH

Pediatric Research

Volumn 50, Issue 6, 2001, Pages 732-736

  Hikino, Shunji ^a   Ihara, Kenji ^a   Yamamoto, Junko ^a   Takahata, Yasushi ^a   Nakayama, Hideki ^a   Kinukawa, Naoko ^a   Narazaki, Yoko ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; GROWTH; HORMONE BLOOD LEVEL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN CARE; PREMATURITY; PRIORITY JOURNAL; RETINOPATHY; VERY LOW BIRTH WEIGHT;

EID: 0035200542     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200112000-00017     Document Type: Article

References (39)

1. Infant growth in the first year of life
2. Fetal growth
3. Role of insulin-like growth factors in embryonic and postnatal growth
4. Mice carrying null mutation of the genes encoding IGF I (Igf-I) and type I IGF receptor (Igflr)
5. Intrauterine growth retardation and growth failure associated with deletion of the IGF I gene
6. Third trimester fetal growth and umbilical venous blood concentrations of IGF-I, IGFBP-1, and GH at term
7. IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: Relationship to birth weight, length and gestational age in healthy newborns
8. Insulin, insulin-like growth factor 1 (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn
9. Secretion and metabolism of GH in premature and full-term infants
10. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
11. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 during the first year in term and preterm infants
12. GH bioactivity and levels of GH, GH-binding protein, IGF I, and IGF-binding proteins in premature and full-term newborns during the first month of life
13. Serum GH levels and the response of diabetic retinopathy to pituitary ablation
14. Long-term effects of transsphenoidal hypophysectomy on GH, renal function and eyeground in patients with diabetic retinopathy
15. Role of GH in diabetes mellitus
16. The role of GH in the development of diabetic retinopathy
17. An international classification of retinopathy of prematurity
18. Response of the IGF-I system to prolonged undernutrition and its involvement in somatic and skeletal muscle growth retardation in rats
19. The anterior pituitary
20. Growth of artificially fed infant rats: Effect of supplementation with IGF I
21. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by IGF-1 receptor
22. hGH stimulates proliferation of human retinal microvascular endothelial cells in vitro
23. Opposing actions of intact and N-terminal fragments of the human prolactin/GH family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis
24. Reduced retinal vascularization in children with GH deficiency
25. Retinal changes mimicking diabetic retinopathy in two nondiabetic, GH-treated patients
26. Full remission of growth hormone (GH)-induced retinopathy after GH treatment discontinuation: Long term follow-up
27. Essential role of GH in ischemia-induced retinal neovascularization
28. Severe retinopathy of prematurity and steroid exposure
29. Perinatal factors associated with retinopathy of prematurity
30. Surfactant replacement therapy: A new risk factor in developing retinopathy of prematurity?
31. Maternal risk factors for retinopathy of prematurity - A population-based study
32. Blood transfusion. Iron load and retinopathy of prematurity
33. High iron stares in very low birth weight infants is associated with an increased risk of retinopathy of prematurity
34. The apparent role of blood transfusions in the development of retinopathy of prematurity
35. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study
36. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy
37. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
38. Vitreous levels of the insulin-like growth factors I and II, and the IGF binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects